Isocitrate dehydrogenase (IDH) mutation is a defining molecular characteristic of a subset of gliomas, particularly low-grade gliomas, including astrocytoma and oligodendroglioma. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).